StemCell Therapy

AUSTIN, Texas, July 6, 2020 /PRNewswire-PRWeb/ --OnlineMedEd, a digital healthcare learning platform, today announced a $5M financing round, raised from more than 20 physicians, founders, and partners of some of the largest physician-owned firms in the United States. The funds will be used to support the expansion of their platform beyond medical school to provide high-quality educational content for the over 60 million healthcare professionals across the globe in specialties ranging from nursing to physician assistants to MD's and DO's.

Today, OnlineMedEd is the clinical learning platform of choice for a broad spectrum of healthcare learners. Over 86% of medical students in the United States are currently using OnlineMedEd to gain the knowledge needed not just to excel in Board exams, but also in clinical practice. In addition to being used by individual med students, OnlineMedEd's suite of products are institutionally used by over 50 universities nationally, and many more around the world.

"Our purpose is to change how medical education is delivered to bring up the quality and performance of the entire healthcare industry," said Jamie Fitch, CEO of OnlineMedEd. "This investment round, raised from highly qualified physicians, further validates the broad demand for OnlineMedEd in the healthcare profession. We're excited to leverage our investors' clinical expertise, professional networks, and business resources as we grow into new markets beyond medical school."

The funding comes at a time when OnlineMedEd is leveraging its education, technology and clinical expertise to support health care professionals beyond medical school in the fight against COVID-19. The company recently launched a Crash Course in Medicine, a suite of 48 free online video lessons aimed at helping redeployed medical professionals get up-to-speed on the medical knowledge they need to confidently provide care in today's environment.

OnlineMedEd has seen an acceleration of adoption since this launch. Prior to the pandemic, they had over 200,000 monthly active users; today, they have over 350,000 monthly active users. In April 2020, the company recorded 27 million minutes of watched video, a more than 100% increase over their healthy baseline of 13 million minutes / month.

"The innovation and reach of OnlineMedEd's comprehensive medical curriculum is exceeded only by the goodwill of their educational mission," says Glenn C. Robinson, M.D., past President of Austin Gastroenterology, P.A. and one of the investors in OnlineMedEd. "The ease and accessibility of its integrative learning tools will be embraced by students and educators alike as a welcomed and timely addition to the traditional learning experience. As an investor, I envision OnlineMedEd's complete solution as merely the DNA base pairs to replicate for the future of all professional education."

In addition to Crash Course, OnlineMedEd provides key learning modules including:

OnlineMedEd was founded in 2014 and is headquartered in Austin, TX. The digital learning platform is currently used in 191 countries.

To learn more about OnlineMedEd, please visit: https://onlinemeded.org.

About OnlineMedEd

OnlineMedEd is a digital healthcare learning platform whose mission is to change how medical education is approached, delivered and learned by healthcare students and institutions alike.

Used in 191 countries and by more than 86% of clinical medical students domestically, the OnlineMedEd learning platform combines technology, education, and data-driven insights to create a comprehensive and personalized experience for its learners, making learning faster, easier, and more reliable. All material is peer-reviewed and developed by physician educators with one goal in mind - making students into better providers.

For more information, visit http://www.onlinemeded.org.

SOURCE OnlineMedEd

Read more:
OnlineMedEd Raises $5M From Physician Networks Across the Nation - Benzinga

This entry was posted on July 6, 2020 at 11:41 pm and is filed under Integrative Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |